AI in Production: What Your CTO Isn’t Telling the Board
Every board deck has a slide about AI. It shows a timeline, a use case, a projected efficiency gain. It usually looks confident. What it rarely shows is what happens after the proof-of-concept passes internal review and someone has to move it into production.

Table of Contents

Share article

Introduction

Every board deck has a slide about AI. It shows a timeline, a use case, a projected efficiency gain. It usually looks confident. What it rarely shows is what happens after the proof-of-concept passes internal review and someone has to move it into production.

That transition — from controlled experiment to live system — is where most AI initiatives quietly accumulate risk. Not the dramatic, headline-making kind. The kind that compounds slowly: in infrastructure costs that weren’t modelled, in compliance gaps that weren’t flagged, in model behavior that works beautifully on test data and unpredictably on real users.

We work with mid-market and enterprise teams across EMEA on exactly this moment. And the pattern we see most often isn’t technical failure — it’s a structural silence between what engineering knows and what leadership is being told. This article is an attempt to name what’s living in that silence.

The Gap Between the Pilot and the Promise

AI pilots are, by design, optimistic environments. The data is clean. The scope is narrow. The team is motivated. Success criteria are generous.
Production is the opposite. Real users don’t follow the test script. Data arrives late, malformed, or in formats the model wasn’t trained on. Edge cases multiply. The system that performed at 94% accuracy in the pilot begins to surface errors at the exact moments that matter most to the business.
This isn’t a technology failure. It’s a diagnosis failure — a gap between what was tested and what was actually built for.
The EU AI Act, which introduces binding obligations for high-risk AI systems deployed across EU member states, is essentially a legislative acknowledgment of this gap. It mandates risk classification, transparency requirements, and human oversight mechanisms — not because regulators distrust AI, but because they understand that production environments are fundamentally different from development ones. Systems that touch hiring, credit, healthcare, critical infrastructure, or law enforcement now carry specific obligations your CTO needs to have mapped before go-live, not after.

What “Production-Ready” Actually Means

Production-readiness in AI is not a binary checkpoint. It is a set of ongoing conditions that have to be engineered and maintained. A model that generates coherent output is not the same as a system that behaves reliably under load, degrades gracefully when the input falls outside training distribution, and produces outputs your compliance team can audit. At SparkEXP, we break production-readiness into four dimensions that we evaluate before any AI system moves to live traffic:

  • Observability. Can the system tell you when it’s failing? Most AI systems in production lack adequate monitoring at the inference layer. Without it, you discover problems through customer complaints, not dashboards.
  • Fallback architecture. What happens when the model returns an unusable output, or the API call to an external LLM times out? A production AI system needs defined failure modes — not just an error handler.
  • Data governance. Under GDPR and, depending on sector, NIS2, the data flowing through your AI system carries obligations. Where is it stored? Who can access inference logs? If your system is processing personal data to generate outputs, that pipeline needs a lawful basis, not just a privacy policy update.
  • Drift management. Models degrade. The statistical distribution of your live data will diverge from your training data over time. Without a monitoring and retraining cadence, a system that works in Q1 may be silently underperforming by Q3.

None of these are unsolvable problems. But they are problems that require explicit planning — and they are the problems most often absent from the board presentation.

The Risks Living Below the Waterline

We’ve observed a consistent pattern across organizations adopting AI at scale: technical teams understand the complexity, but they’re not always equipped to translate it into language that reaches the people making budget and governance decisions.

The result is a set of risks that sit below the waterline of leadership visibility.

Infrastructure cost is the most immediate. Running inference at scale — particularly with large language models — is significantly more expensive than running a conventional application. Costs scale with usage in ways that are non-linear and genuinely difficult to predict before production traffic arrives. We’ve seen teams discover their unit economics only work at a usage volume they won’t reach for eighteen months.

Vendor concentration is the second. Many AI implementations now depend on APIs controlled by a small number of providers. When pricing changes, when availability degrades, when a provider’s terms of service shift — organizations with deep API dependencies have limited recourse. This is a supply chain risk that most enterprise risk registers have not yet caught up with.

Regulatory exposure is the third, and the one with the longest tail. The EU AI Act’s enforcement timeline is running. GDPR obligations on automated decision-making under Article 22 are not new, but their intersection with modern AI pipelines is poorly understood in many organizations. If your AI system makes or substantially influences decisions about individuals, you may have obligations around explainability and human review that are not currently being met.

What the Board Should Be Asking

If you’re a CEO, CFO, or board member trying to close this visibility gap, these are the questions that tend to surface the most important answers:

  • What is our failure mode when this system produces a wrong output at scale — and who owns the response?
  • What compliance review has been completed specific to the EU AI Act risk classification for this use case?
  • What is the cost model at 3x our projected usage, and do our margins still hold?
  • What is our contractual and technical exposure if our primary AI provider changes pricing or availability?
  • Has a named individual been assigned responsibility for ongoing model performance monitoring — and what is their reporting line?

These aren’t hostile questions. They’re the questions a well-governed organization should be able to answer before, not after, an AI system goes live. If the answers aren’t ready, that’s the diagnosis, not the technology.

Conclusion

The problem with AI in production isn’t that it’s too hard. It’s that the distance between a successful pilot and a well-governed production system is longer than most organizations plan for — and that distance is rarely visible to leadership until something goes wrong.

We built SparkEXP around the belief that better diagnosis before a project starts is worth more than better engineering after a problem surfaces. That applies to AI systems more than almost anything else we build.
The board doesn’t need to become technical. It needs the right questions on the agenda before the budget is committed.

If your organization is moving AI from pilot to production and you want an honest assessment of what’s not yet in the room, we’d welcome the conversation.

SparkEXP works with engineering and leadership teams across EMEA to identify the risks that don’t make it into presentations — before they become production incidents.